|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7250 NOK | +9.02% |
|
-3.33% | -47.46% |
| 30/06 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| 26/06 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9.02% | -3.33% | -7.05% | -54.11% | -47.46% | -75.83% | -93.70% | -96.28% | - | 4.74M | |
| -0.17% | +1.47% | +17.45% | +8.92% | +8.11% | +3.16% | +6.80% | -11.10% | +246.28% | 50.35B | |
| -0.29% | -2.81% | +15.23% | +20.91% | +131.56% | +387.81% | +591.82% | +529.70% | - | 39.21B | |
| -0.49% | +1.48% | +15.93% | +16.12% | -8.25% | +31.16% | -6.46% | -16.10% | +188.56% | 34.52B | |
| +1.53% | +3.11% | +16.06% | -2.71% | +2.45% | +15.41% | +58.54% | -6.22% | +953.69% | 34.6B | |
| +1.68% | -0.62% | +0.40% | -8.67% | +1.93% | +3.30% | +27.34% | -19.81% | +149.78% | 27.05B | |
| +1.13% | -3.11% | +20.28% | - | - | - | - | - | - | 16.68B | |
| -1.29% | -0.52% | +13.20% | +2.06% | -5.77% | +69.24% | +117.60% | +190.55% | - | 15.11B | |
| +0.43% | +3.34% | +9.34% | -0.20% | +11.06% | +14.96% | +17.46% | -31.83% | +107.52% | 13.85B | |
| +2.45% | +3.99% | +16.49% | +47.71% | -5.56% | +18.20% | -30.12% | -19.91% | +140.20% | 13.18B | |
| +0.93% | -1.88% | +40.78% | +15.64% | -0.50% | +1,412.63% | +644.10% | +292.79% | +2,686.05% | 11.81B | |
| -1.29% | +1.90% | +21.09% | +26.40% | +14.41% | +47.79% | +9.95% | -40.28% | +166.55% | 10.99B | |
| +0.35% | +0.73% | +27.26% | +22.21% | +21.54% | +39.01% | -15.13% | -36.39% | +157.77% | 11.14B | |
| -2.42% | -0.03% | +9.42% | +1.49% | -3.05% | +2.43% | - | - | - | 10.28B | |
| +0.25% | +0.78% | +55.81% | +50.35% | +77.91% | +261.58% | +532.55% | - | - | 10.06B | |
| +1.82% | -0.04% | +33.33% | +28.22% | +46.66% | +154.11% | +415.45% | +137.16% | - | 9.39B | |
| +9.13% | +32.96% | +79.35% | +28.75% | +41.75% | +52.02% | +51.20% | -61.13% | - | 9.94B | |
| -2.83% | -4.38% | +20.37% | -6.33% | +8.03% | +513.64% | +1,745.91% | +23.35% | - | 8.88B | |
| -0.36% | -35.20% | -26.00% | -28.76% | -30.82% | +30.31% | +28.84% | +53.43% | +100.62% | 9.04B | |
| +0.74% | -4.25% | +17.18% | +56.47% | +85.78% | +80.17% | +70.76% | +119.79% | +9.25% | 8.66B | |
| Average | +1.02% | -0.40% | +19.80% | +11.81% | +18.41% | +161.11% | +231.83% | +59.28% | +446.02% | 17.24B | |
| Weighted average by Cap. | +0.47% | +0.33% | +18.42% | +12.56% | +24.22% | +141.28% | +193.21% | +84.81% | +424.52% |
- Stock Market
- Stocks
- EXTX Stock
- Sector EXACT Therapeutics
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
